United States · FDA National Drug Code directory
Tolterodine Tartrate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70436-161_5849c8cc-3ff6-8feb-e063-6394a90a2953
- Product NDC
- 70436-161
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- Tolterodine Tartrate
- Labeler
- Slate Run Pharmaceuticals, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210412
- Source listing expiry
- 20271231
Source-listed ingredients
- TOLTERODINE TARTRATE — 4 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70436-161-02) · 70436-161-02
- 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70436-161-04) · 70436-161-04
- 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70436-161-06) · 70436-161-06
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →